AVANOS MEDICAL INC (AVNS) Stock Overview
USA - NYSE:AVNS - US05350V1061 - Common Stock
AVNS Key Statistics, Chart & Performance
The current stock price of AVNS is 12.22 USD. In the past month the price increased by 11.5%. In the past year, price decreased by -49.08%.
AVNS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 25.92 | 39.12B | ||
| COO | COOPER COS INC/THE | 16.59 | 13.30B | ||
| SOLV | SOLVENTUM CORP | 12.07 | 12.73B | ||
| ALGN | ALIGN TECHNOLOGY INC | 13.98 | 9.54B | ||
| BLCO | BAUSCH + LOMB CORP | 36.17 | 5.38B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.37 | 5.07B | ||
| LNTH | LANTHEUS HOLDINGS INC | 8.28 | 3.60B | ||
| ICUI | ICU MEDICAL INC | 17.34 | 3.22B | ||
| XRAY | DENTSPLY SIRONA INC | 7.91 | 2.70B | ||
| HAE | HAEMONETICS CORP/MASS | 11.23 | 2.51B | ||
| UFPT | UFP TECHNOLOGIES INC | 23.1 | 1.54B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.36B |
Related stock screener links
About AVNS
Company Profile
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Its segment includes Specialty Nutrition Systems and Pain Management and Recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which includes products such as MIC-KEY enteral feeding tubes and Corpak patient feeding solutions and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products used to treat chronic pain conditions.
Company Info
AVANOS MEDICAL INC
5405 Windward Parkway, Suite 100 South
Alpharetta GEORGIA 30004 US
CEO: Joseph F. Woody
Employees: 2227
Phone: 18444282667
AVANOS MEDICAL INC / AVNS FAQ
What is the stock price of AVANOS MEDICAL INC today?
The current stock price of AVNS is 12.22 USD. The price decreased by -1.53% in the last trading session.
What is the ticker symbol for AVANOS MEDICAL INC stock?
The exchange symbol of AVANOS MEDICAL INC is AVNS and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is AVNS stock listed?
AVNS stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for AVANOS MEDICAL INC stock?
6 analysts have analysed AVNS and the average price target is 17.34 USD. This implies a price increase of 41.9% is expected in the next year compared to the current price of 12.22. Check the AVANOS MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AVANOS MEDICAL INC worth?
AVANOS MEDICAL INC (AVNS) has a market capitalization of 567.01M USD. This makes AVNS a Small Cap stock.
How many employees does AVANOS MEDICAL INC have?
AVANOS MEDICAL INC (AVNS) currently has 2227 employees.
What are the support and resistance levels for AVANOS MEDICAL INC (AVNS) stock?
AVANOS MEDICAL INC (AVNS) has a support level at 12.03 and a resistance level at 12.52. Check the full technical report for a detailed analysis of AVNS support and resistance levels.
Is AVANOS MEDICAL INC (AVNS) expected to grow?
The Revenue of AVANOS MEDICAL INC (AVNS) is expected to decline by -1.38% in the next year. Check the estimates tab for more information on the AVNS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AVANOS MEDICAL INC (AVNS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AVNS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AVNS, evaluating the profitability, health, valuation and growth aspects
- AVANOS MEDICAL INC (AVNS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AVANOS MEDICAL INC (AVNS) Sales and EPS estimates to see what analysts future expectations are.
- AVANOS MEDICAL INC (AVNS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AVANOS MEDICAL INC (AVNS) Insider and Institutional Ownership to learn about the owners and their transactions.
- AVANOS MEDICAL INC (AVNS) Stock Chart to make your own analysis
- AVANOS MEDICAL INC (AVNS) Latest news and press-releases to stay up to date.
Does AVANOS MEDICAL INC (AVNS) stock pay dividends?
AVNS does not pay a dividend.
When does AVANOS MEDICAL INC (AVNS) report earnings?
AVANOS MEDICAL INC (AVNS) will report earnings on 2025-10-28, before the market open.
What is the Price/Earnings (PE) ratio of AVANOS MEDICAL INC (AVNS)?
The PE ratio for AVANOS MEDICAL INC (AVNS) is 10.1. This is based on the reported non-GAAP earnings per share of 1.21 and the current share price of 12.22 USD. Check the full fundamental report for a full analysis of the valuation metrics for AVNS.
What is the Short Interest ratio of AVANOS MEDICAL INC (AVNS) stock?
The outstanding short interest for AVANOS MEDICAL INC (AVNS) is 5.36% of its float. Check the ownership tab for more information on the AVNS short interest.
AVNS Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to AVNS. When comparing the yearly performance of all stocks, AVNS is a bad performer in the overall market: 91.38% of all stocks are doing better.
AVNS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AVNS. AVNS has only an average score on both its financial health and profitability.
AVNS Financial Highlights
Over the last trailing twelve months AVNS reported a non-GAAP Earnings per Share(EPS) of 1.21. The EPS decreased by -0.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -44.57% | ||
| ROE | -59.68% | ||
| Debt/Equity | 0.12 |
AVNS Forecast & Estimates
6 analysts have analysed AVNS and the average price target is 17.34 USD. This implies a price increase of 41.9% is expected in the next year compared to the current price of 12.22.
For the next year, analysts expect an EPS growth of -35.56% and a revenue growth -1.38% for AVNS